The diagnosis of bacterial endocarditis remains a challenge, as nearly half of cases develop in the absence of preexistent heart disease and known risk factors. Not infrequently, a blunted clinical course at onset can lead to erroneous diagnoses. We present the case of a 47-year-old previously healthy man in which a presumptive diagnosis of antiphospholipid syndrome was made based on the absence of echocardiographically detected heart involvement, a negative blood culture, normal C-reactive protein (CRP) levels, a positive lupus anticoagulant (LAC) test, and evidence of splenic infarcts. The patient eventually developed massive aortic endocarditic involvement, with blood cultures positive for Streptococcus bovis, and was referred for valvular replacement. This case not only reminds us of the diagnostic challenges of bacterial endocarditis, but also underlines the need for a critical application of antiphospholipid syndrome diagnostic criteria. 1. Introduction Antiphospholipid syndrome (APS) and infective endocarditis (IE) are difficult-to-diagnose diseases and share several clinical features. To increase the probability of excluding temporary infection-associated antibodies, current diagnostic criteria for APS require Antiphospholipid Antibodies (APA) positivity on two separate occasions at least twelve weeks apart [1]. We describe here the case of a 47-year-old male in whom an erroneous diagnosis of presumptive APS, waiting for confirmatory laboratory test, was made, leading to a potentially dangerous delay in the treatment of infective endocarditis. The diagnostic challenges presented by this patient are discussed. 2. Case Report A 47-year-old previously healthy man was admitted to our department because of arthralgias, remittent fever, and pericardial effusion. His medical history was unremarkable. Approximately one year earlier he had had an episode of paroxysmal atrial fibrillation with pharmacological restoration of sinus rhythm. For the past six months before admission, he reported remittent low-grade fever, tachycardia, night sweats, cervical pain, and migratory arthralgias with transient joint swelling. The patient was evaluated by an internal medicine specialist. Blood test revealed WBC 7.000/mmc, Hb 14.0?g/dL, and C-reactive protein (CRP) 9.3?mg/L. C3 and C4 complement components were within normal limits, and antinuclear antibodies were absent. A small IgG-K monoclonal gammopathy (7.94?g/L) was detected, with negative Bence-Jones proteinuria. A blood culture was negative. Silica clotting time, lupus anticoagulant (LAC) screening (LAR 1.97),
References
[1]
S. Miyakis, M. D. Lockshin, and M. D. Lockshin, “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006.
[2]
G. Habib, B. Hoen, and B. Hoen, “Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC),” European Heart Journal, vol. 30, no. 19, pp. 2369–2413, 2009.
[3]
B. Hoen, F. Alla, C. Selton-Suty, et al., “Association pour l'Etude et la Prévention de l'Endocardite infectieuse (AEPEI) study group. Changing profile of infective endocarditis: results of a 1-year survey in France,” Journal of the American Medical Association, vol. 288, pp. 75–81, 2002.
[4]
J. Corredoira, M. P. Alonso, and M. P. Alonso, “Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 27, no. 4, pp. 285–291, 2008.
[5]
J. S. Gold, S. Bayar, and R. R. Salem, “Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy,” Archives of Surgery, vol. 139, no. 7, pp. 760–765, 2004.
[6]
I. Palomo, F. Segovia, C. Ortega, and S. Pierangeli, “Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease,” Clinical and Experimental Rheumatology, vol. 27, no. 4, pp. 668–677, 2009.
[7]
J. J. Silbiger, “The cardiac manifestations of antiphospholipid syndrome and their echocardiographic recognition,” Journal of the American Society of Echocardiography, vol. 22, no. 10, pp. 1100–1108, 2009.
[8]
A. Farzaneh-Far, M. J. Roman, and M. J. Roman, “Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 54, no. 12, pp. 3918–3925, 2006.
[9]
C. A. Roldan, “Valvular and coronary heart disease in systemic inflammatory diseases,” Heart, vol. 94, no. 8, pp. 1089–1101, 2008.
[10]
M. García-Carrasco, C. Galarza-Maldonado, C. Mendoza-Pinto, R. O. Escarcega, and R. Cervera, “Infections and the antiphospholipid syndrome,” Clinical Reviews in Allergy and Immunology, vol. 36, no. 2-3, pp. 104–108, 2009.
[11]
R. Ozaras, B. Mete, and B. Mete, “Primary antiphospholipid syndrome: a cause of fever of unknown origin,” Internal Medicine, vol. 42, no. 4, pp. 358–361, 2003.
[12]
M. Hojnik, J. George, L. Ziporen, and Y. Shoenfeld, “Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome,” Circulation, vol. 93, no. 8, pp. 1579–1587, 1996.
[13]
J. S. Li, D. J. Sexton, and D. J. Sexton, “Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis,” Clinical Infectious Diseases, vol. 30, no. 4, pp. 633–638, 2000.
[14]
E. Cecchi, R. Trinchero, and R. Trinchero, “Are the Duke criteria really useful for the early bedside diagnosis of infective endocarditis? Results of a prospective multicenter trial,” Italian Heart Journal, vol. 6, no. 1, pp. 41–48, 2005.
[15]
A. Evangelista and M. T. González-Alujas, “Echocardiography in infective endocarditis,” Heart, vol. 90, no. 6, pp. 614–617, 2004.
[16]
K. Greaves, D. Mou, A. Patel, and D. S. Celermajer, “Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis,” Heart, vol. 89, no. 3, pp. 273–275, 2003.
[17]
V. Kini, S. Logani, and S. Logani, “Transthoracic and transesophageal echocardiography for the indication of suspected infective endocarditis: vegetations, blood cultures and imaging,” Journal of the American Society of Echocardiography, vol. 23, no. 4, pp. 396–402, 2010.
[18]
K. J. Lackner, D. Peetz, and P. Von Landenberg, “Revision of the Sapporo criteria for the antiphospholipid syndrome—coming to grips with evidence and Thomas Bayes?” Thrombosis and Haemostasis, vol. 95, no. 6, pp. 917–919, 2006.